Related Experiment Videos
Potential applications of gene therapy in the patient with cancer
1Department of Medical Oncology, Guy's Hospital, London, England. szlos@doctors.org.uk
Abstract:
The elderly population has much to gain from the advances of molecular medicine, although at present genetic pharmacology remains mostly at the conceptual level. Cancer, in particular, is an increasing health burden and the majority (over 70%) of gene therapy trials are aimed at tackling this problem. Available strategies employ both viral and synthetic vectors with the selective delivery and expression of therapeutic genes a pivotal requirement. Clinical trials are now in progress with a view to modulating disease at many different levels, including the direct replacement of abnormal genes. suicide-gene formulations, and the delivery of 'gain of function' genes, which seek to alter the malignant phenotype by indirect means, such as, immunopotentiation and stromal reorganisation. Early data from these studies is tantalising and we must remain optimistic that gene therapy will benefit the patient with cancer by both reducing morbidity and extending life.
Insights
Molecular medicine advances, particularly gene therapy, offer hope for elderly cancer patients. Ongoing trials explore various gene delivery strategies to combat cancer, aiming to reduce illness and extend lives.
Area of Science:
- Geriatric Medicine
- Oncology
- Molecular Medicine
- Pharmacology
Background:
- The elderly population stands to benefit significantly from molecular medicine advancements.
- Genetic pharmacology, while promising, is largely conceptual currently.
- Cancer represents a growing health challenge, with over 70% of gene therapy trials targeting this disease.
Purpose of the Study:
- To review the current state and potential of gene therapy in treating cancer, especially in the elderly.
- To highlight the diverse strategies being explored in gene therapy for cancer treatment.
- To discuss the implications of gene therapy for patient morbidity and longevity.
Main Methods:
- Review of current gene therapy strategies for cancer.
- Analysis of viral and synthetic vector applications.
- Examination of clinical trial approaches, including gene replacement, suicide gene therapy, and gain-of-function gene delivery.
Main Results:
- Gene therapy trials are actively investigating methods to modulate cancer at multiple levels.
- Strategies include direct gene replacement, suicide gene formulations, and gain-of-function genes to alter malignant phenotypes.
- Early clinical data suggests promising outcomes for cancer treatment through gene therapy.
Conclusions:
- Gene therapy holds significant potential for the elderly cancer patient population.
- Selective delivery and expression of therapeutic genes are critical for successful treatment.
- Optimism is warranted for gene therapy's role in reducing cancer morbidity and extending patient survival.